CME vs MCO vs NOW Stock Comparison

Cme, Moodys and ServiceNow Prices as of Nov 13, 2026 Peers: Industry group
CME Cme Group Inc.
$317.97 +11.3% 1M +12.1% 1Y
Market cap
$114.01B
P/E
25.8x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
9 wins
MCO Moodys Corp /De/
$508.27 +9.8% 1M +3.6% 1Y
Market cap
$87.25B
P/E
30.3x
Revenue (TTM)
$8.18B
Div. yield
0.01%
Financial Data and Analytics Financial Services
1 win
NOW ServiceNow, Inc.
$102.26 -27.0% 1M -39.8% 1Y
Market cap
$104.14B
P/E
72.1x
Revenue (TTM)
$15.43B
Div. yield
–
Business Process Automation Technology
1 win

Head to Head

11 decided of 12

Cme leads on 9 of the 12 questions below (Cme 9, ServiceNow 1, Moodys 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCMEMCONOWLeader
Larger companyMarket capitalisation $114.01B $87.25B $104.14B CME
Cheaper on earningsLower P/E, profitable companies only 25.8x 30.3x 72.1x CME
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.1x 28.4x 27.3x CME
Faster revenue growthRevenue growth, trailing twelve months +9.0% +9.0% +21.8% NOW
More profitableNet margin, trailing twelve months 63.3% 35.3% 9.4% CME
Better return on capitalReturn on invested capital 11.7% 27.9% 5.2% MCO
Less leveragedLower net debt / EBITDA 0.2x 1.3x 0.8x CME
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months +12.1% +3.6% -39.8% CME
Better 5-year returnAnnualised price return, 5 years +7.2%/yr +5.6%/yr -5.9%/yr CME
Less volatileAnnualised volatility, 1 year 25.5% 28.9% 67.1% CME
Higher overall scoreMean of the five percentile scores vs peers 63/100 59/100 54/100 CME

Percentile Scorecard

CMEMCONOW

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCMEMCONOW
Valuation 53 #63 of 134 26 #826 of 1108 45 #59 of 106
Growth 30 #59 of 84 70 #266 of 897 50 #51 of 101
Profitability 87 #12 of 88 96 #35 of 922 76 #25 of 100
Financial Health 51 #75 of 151 47 #585 of 1098 53 #55 of 117
Shareholder Returns 92 #5 of 49 54 #346 of 758 44 #40 of 70
Overall 63 59 54
  • CME ranked among 158 companies in Capital Markets
  • MCO ranked among 1,197 companies in Financial Services
  • NOW ranked among 117 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCMEMCONOWSPY
1 month +11.3%+9.8%-27.0% -2.0%
3 months +17.9%+4.8%-17.6% -2.8%
6 months +6.4%+18.5%+7.6% +2.0%
Year to date +16.4%-0.5%-33.2% +10.6%
1 year +12.1%+3.6%-39.8% +12.2%
3 years +50.2%+44.7%-21.8% +68.1%
3 years, per year +14.5%+13.1%-7.9% +18.9%
5 years +41.4%+31.0%-26.0% +61.4%
5 years, per year +7.2%+5.6%-5.9% +10.1%
10 years +178.0%+406.0%+518.6% +248.5%
10 years, per year +10.8%+17.6%+20.0% +13.3%

Risk

MeasureCMEMCONOWSPY
Volatility, 1Y 25.5%28.9%67.1% 13.6%
Downside volatility, 1Y 27.2%30.3%76.9% 13.9%
Beta vs S&P 500, 1Y -0.300.530.79 1.00
Return / volatility, 1Y 0.480.12-0.59 0.90
Max drawdown, 5Y -33.1%-41.4%-64.5% -25.4%
From 52-week high -2.6%-5.8%-41.1% -3.2%
52-week high $326.46$539.61$173.50 $779.14
52-week low $218.58$412.23$83.00 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCMEMCONOW
P/E now vs peer median 25.8xmedian 42.3x 30.5xmedian 14.9x 73.2xmedian 25.9x
P/S now vs peer median 16.3xmedian 3.9x 10.7xmedian 3.2x 6.9xmedian 3.0x
EV/EBITDA now vs peer median 23.4xmedian 12.7x 22.4xmedian 6.3x 31.6xmedian 14.9x
P/FCF now vs peer median 26.2xmedian 16.5x 29.4xmedian 10.5x 22.3xmedian 15.7x
P/B now vs peer median 4.3xmedian 3.7x 25.7xmedian 1.3x 8.1xmedian 2.8x
PEG now vs peer median 1.88median 0.52 1.15median 0.89 -21.43median 0.86

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCMEMCONOW
Revenue $6.97B $8.18B $15.43B
Gross profit $1.37B $6.10B $11.28B
Operating income $4.58B $3.64B $1.49B
Net income $4.42B $2.89B $1.45B
Free cash flow $4.33B $2.98B $4.75B
R&D – – $3.47B
EPS (diluted) $12.31 $16.64 $1.39
Cash & equivalents $2.20B $1.51B $2.39B
Total debt $3.43B $6.91B $7.52B
Shares (diluted) 358.64M 173.30M 1.04B
Enterprise value $102.35B $80.18B $83.40B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCMEMCONOW
P/E 25.8x 30.5x 73.2x
P/FCF 26.2x 29.4x 22.3x
P/Operating cash flow 25.7x 26.3x 19.9x
P/S 16.3x 10.7x 6.9x
P/B 4.3x 25.7x 8.1x
P/Tangible book 4.7x 51.0x 11.2x
EV/EBITDA 23.4x 22.4x 31.6x
EV/EBIT 25.1x 25.5x 73.0x
EV/Revenue 16.5x 11.4x 7.1x
EV/FCF 26.5x 31.2x 23.0x
EV/Operating cash flow 25.9x 27.9x 20.4x
PEG (3Y EPS CAGR) 1.88 1.15 -21.43

Growth

14 metrics
MetricCMEMCONOW
Revenue growth (1Y) 9.0% 9.0% 21.8%
Revenue CAGR (3Y) 9.2% 12.6% 22.1%
Gross profit growth (1Y) 13.2% 10.3% 14.1%
Gross profit CAGR (3Y) 12.5% 14.6% 19.2%
Operating income growth (1Y) 10.1% 16.0% -14.9%
Operating income CAGR (3Y) 12.2% 23.3% 32.1%
Net income growth (1Y) 17.3% 28.5% -16.5%
Net income CAGR (3Y) 13.1% 24.0% -3.1%
EPS growth (1Y) 19.4% 33.1% -16.2%
EPS CAGR (3Y) 13.7% 26.5% -3.4%
Operating cash flow growth (1Y) 6.4% 22.5% 10.2%
Operating cash flow CAGR (3Y) 9.3% 17.5% 21.8%
Free cash flow growth (1Y) 6.1% 24.1% 20.0%
Free cash flow CAGR (3Y) 9.4% 18.8% 25.9%

Profitability

14 metrics
MetricCMEMCONOW
Gross margin 19.7% 74.6% 73.1%
EBITDA margin 70.4% 50.6% 22.3%
Operating margin 65.7% 44.6% 9.7%
Pretax margin 82.8% 45.2% 13.1%
Net margin 63.3% 35.3% 9.4%
FCF margin 62.1% 36.4% 30.8%
Operating cash flow margin 63.5% 40.7% 34.6%
Return on equity 16.6% 87.8% 9.3%
Return on assets 2.3% 19.6% 3.7%
Return on invested capital 11.7% 27.9% 5.2%
Return on capital employed 12.3% 31.8% 7.5%
Asset turnover 0.0x 0.6x 0.5x
Cash conversion (OCF / net income) 1.0x 1.2x 3.7x
Stock comp / revenue 1.4% 2.8% 10.4%

Financial Health

11 metrics
MetricCMEMCONOW
Debt / assets 1.8% 46.6% 23.6%
Debt / equity 0.1x 2.0x 0.6x
Net debt / EBITDA 0.2x 1.3x 0.8x
Debt / FCF 0.8x 2.3x 1.6x
Liabilities / assets 86.2% 77.0% 58.9%
Equity / assets 13.8% 23.0% 41.1%
Interest coverage 26.2x – 14.6x
Current ratio 1.0x 1.3x 0.7x
Quick ratio 0.0x 1.3x 0.6x
Cash ratio 0.0x 0.5x 0.4x
Altman Z-score 0.59 7.89 4.19

Shareholder Returns

7 metrics
MetricCMEMCONOW
Dividend yield 3.1% 0.8% –
Net buyback yield – 3.4% 2.4%
Shareholder yield 3.1% 4.2% 2.4%
Payout ratio (earnings) – 24.6% –
Payout ratio (FCF) – 23.8% –
Dividend growth (1Y) – 3.0% –
Dividend CAGR (3Y) – 8.8% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCMEMCONOW
Forward P/E 27.1xFY2026 28.4xFY2026 27.3xFY2026
EPS, next fiscal year $11.75FY2026 $17.92FY2026 $3.74FY2026
EPS growth, next FY +4.9%FY2026 +19.9%FY2026 +6.6%FY2026
EPS growth, the year after +19.3% -1.7% +25.1%
Revenue, next fiscal year $7.27BFY2026 $8.68BFY2026 $15.26BFY2026
Revenue growth, next FY +11.6%FY2026 +12.5%FY2026 +14.9%FY2026
Revenue growth, the year after +7.0% -2.0% +17.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCMEMCONOW
Held by institutions 88.9% 90.8% 81.6%
Institutions holding 1,694 1,408 2,228
Change in shares held, QoQ +0.4% -1.6% -2.1%
Institutions buying 824 645 1,287
Institutions selling 656 525 781
Buyers to sellers 1.26 1.23 1.65

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CMEMCONOW
CME 1.00 0.17 0.06
MCO 0.17 1.00 0.34
NOW 0.06 0.34 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CME, MCO and NOW?

Cme (CME) is the largest by market capitalisation: Cme (CME) $114.01B, Moodys (MCO) $87.25B, ServiceNow (NOW) $104.14B.

Which stock is cheaper, CME, MCO and NOW?

Cme (CME) trades on the lowest price-to-earnings ratio (Cme (CME) 25.8x, Moodys (MCO) 30.3x, ServiceNow (NOW) 72.1x). On next year's consensus earnings, Cme (CME) is cheapest (Cme (CME) 27.1x, Moodys (MCO) 28.4x, ServiceNow (NOW) 27.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

ServiceNow (NOW) grew revenue fastest over the trailing twelve months: Cme (CME) +9.0%, Moodys (MCO) +9.0%, ServiceNow (NOW) +21.8%.

Which company is more profitable?

Cme (CME) has the highest net margin (Cme (CME) 63.3%, Moodys (MCO) 35.3%, ServiceNow (NOW) 9.4%). On return on invested capital, Moodys (MCO) leads (Cme (CME) 11.7%, Moodys (MCO) 27.9%, ServiceNow (NOW) 5.2%).

Which stock has performed better?

Over the past year Cme (CME) returned the most: Cme (CME) +12.1%, Moodys (MCO) +3.6%, ServiceNow (NOW) -39.8%. Over five years, Cme (CME) compounded fastest (Cme (CME) +7.2%/yr, Moodys (MCO) +5.6%/yr, ServiceNow (NOW) -5.9%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cme (CME) 0.00%, Moodys (MCO) 0.01%, ServiceNow (NOW) 0.00%. Cme (CME) and ServiceNow (NOW) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cme (CME) has been the steadiest (Cme (CME) 25.5%, Moodys (MCO) 28.9%, ServiceNow (NOW) 67.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CME, MCO and NOW?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cme (CME) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.